⌘K
Loading ticker…
Novavax Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Novavax Inc (NVAX) has a 3-month relative strength percentile of 38 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 6.7%, relative volume 1.78×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
38 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
NVAX is held by 8 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $42M notional. Top 3 carry $110M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $42M |
| XBIState Street SPDR S&P Biotech ETF | 0.51% | $38M |
| VBVanguard Small Cap ETF | 0.02% | $31M |
| IWMiShares Russell 2000 ETF | 0.04% | $30M |
| VBKVanguard Small-Cap Growth ETF | 0.04% | $17M |
| VXFVanguard Extended Market ETF | 0.02% | $15M |
| IWOiShares Russell 2000 Growth ETF | 0.07% | $8M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $2M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NVAX Jan avg: 7.29% median: 7.11% win: 75% σ: 19.73% n: 4 2022-04-12 → 2026-05-29 | NVAX Feb avg: 4.72% median: 5.25% win: 50% σ: 17.54% n: 4 2022-04-12 → 2026-05-29 | NVAX Mar avg: -17.79% median: -21.39% win: 0% σ: 9.96% n: 4 2022-04-12 → 2026-05-29 | NVAX Apr avg: -3.80% median: -2.64% win: 40% σ: 12.49% n: 5 2022-04-12 → 2026-05-29 | NVAX May avg: 64.66% median: 22.77% win: 100% σ: 102.81% n: 5 2022-04-12 → 2026-05-29 | NVAX Jun avg: -11.17% median: -10.94% win: 0% σ: 4.44% n: 4 2022-04-12 → 2026-05-29 (current) | NVAX Jul avg: 9.41% median: 5.77% win: 100% σ: 10.55% n: 4 2022-04-12 → 2026-05-29 | NVAX Aug avg: -11.05% median: -8.58% win: 25% σ: 21.73% n: 4 2022-04-12 → 2026-05-29 | NVAX Sep avg: -9.08% median: -3.74% win: 50% σ: 26.07% n: 4 2022-04-12 → 2026-05-29 | NVAX Oct avg: -3.17% median: -5.56% win: 25% σ: 19.20% n: 4 2022-04-12 → 2026-05-29 | NVAX Nov avg: -17.18% median: -16.74% win: 0% σ: 6.86% n: 4 2022-04-12 → 2026-05-29 | NVAX Dec avg: -15.72% median: -10.26% win: 0% σ: 15.00% n: 4 2022-04-12 → 2026-05-29 |